| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |